Multicenter evaluation of a nonweekend reading schedule for radiometric pyrazinamide susceptibility testing of Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 40, Issue 10, 2002, Pages 3753-3756

  Madison, B ^a   Gross, W ^a   George, I ^a   Sloutsky, A ^a   Washabaugh, G ^a   Robinson Dunn, B ^a   Lipman, H ^a   Metchock, B ^a   Mazurek, G ^a   Ridderhof, J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATE; DEVICE; DRUG SENSITIVITY; LABORATORY TEST; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOMETRY; REPRODUCIBILITY; STAFF;

ANTITUBERCULAR AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; PYRAZINAMIDE; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0036792169     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.10.3753-3756.2002     Document Type: Article

References (21)

1. Butler, W. R., and J. O. Kilburn. 1982. Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J. Clin. Microbiol. 6:1106-1109.
2. Centers for Disease Control and Prevention. 1993. Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis. Morb. Mortal. Wkly. Rep. 42(No. RR-7):1-8.
3. Davies, A. P., O. J. Billington, T. D. McHugh, D. A. Mitchison, and T. P. Gillis. 2000. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J. Clin. Microbiol. 38:3686-3688.
4. Hawkins, J. E. 1986. Nonweekend schedule for BACTEC drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 23:934-937.
5. Heifets, L., and T. Sanchez. 2000. New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J, Clin. Microbiol. 38:1498-1501.
6. Hewlett, D., D. L. Horn, and C. Alfalla. 1995. Drug resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing. JAMA 273:916-917.
7. Libonati, J. P., C. E. Stager, J. R. Davis, and S. H. Siddiqi. 1988. Direct antimicrobial drug susceptibility testing of Mycobacterium tuberculosis by the radiometric method. Diagn. Microbiol. Infect. Dis. 10:41-48.
8. Marttila, H., M. Marjamaki, E. Vyshvskaya, et al. 1999. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia. Antimicrob. Agents Chemother. 43:1764-1766.
9. NCCLS. 2000. Tentative standard M24-T2. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes, 2nd ed. NCCLS, Wayne, Pa.
10. Raynaud, C., M. A. Laneelle, R. H. Senaratne, P. Draper, G. Laneelle, and M. Daffe. 1999. Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity. Microbiology 145:1359-1367.
11. Salfinger, M., L. B. Reller, B. Demchuk, and Z. T. Johnson. 1989. Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Res. Microbiol. 140:301-309.
12. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamide/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
13. Scorpio, A., P. Lindholm-Levy, L. Heifets, R. Gilman, S. Siddiqi, M. Cynamon, and Y. Zhang. 1997. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:540-543.
14. Speirs, R. J., J. T. Welch, and M. H. Cynamon. 1995. Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide. Antimicrob. Agents Chemother. 39:1269-1271.
15. Sreevatsan, S., X. Pan, Y. Zhang, B. N. Kreiswirth, and J. M. Musser. 1997. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob. Agents Chemother. 41:636-640.
16. Stottmeier, K. D., R. E. Beam, and G. P. Kubica. 1967. Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar. Am. Rev. Respir. Dis. 96:1072-1075.
17. Tarrand, J. J. 1986. Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 30:852-855.
18. Tenover, F., J. T. Crawford, R. E. Hubner, L. J. Geiter, C. R. Horsburgh, Jr., and R. C. Good. 1993. The resurgence of tuberculosis: is your laboratory ready? J. Clin. Microbiol. 31:767-770.
19. Wayne, L. G. 1974. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am. Rev. Respir. Dis. 109:147-151.
20. Woodley, C., and R. W. Smithwick. 1988. Radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis in egg yolk-enriched BACTEC 12A medium. Antimicrob. Agents Chemother. 32:125-127.
21. Zhang. Y., S. Permar, and Z. Sun. 2002. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J. Med. Microbiol. 51:42-49.